Concepedia
Statistics
Publications
30
Citations
1.8K
H-Index
23
Active since
1993
Affiliations
Pfizer (United States)(Current)
Albert Einstein College of Medicine
Pearl River Community College
Montefiore Medical Center
Ziopharm Oncology (United States)
Sylvia Musto is an author at Pfizer (United States) specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
1993–2019
Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
Frank Loganzo, Xingzhi Tan, Matthew Sung et al. · Molecular Cancer Therapeutics · 2015 · 270 citations
Medicine, Immunology, Oncology +17
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules
Malathi Hari, Frank Loganzo, Tami Annable et al. · Molecular Cancer Therapeutics · 2006 · 147 citations
Medicine, Oncology, Pharmacology +17
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
Frank Loganzo, Carolyn Discafani, Tami Annable et al. · PubMed · 2003 · 137 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications
Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam et al. · Journal of Medicinal Chemistry · 2014 · 132 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide
Damien Mailhol, Jens Willwacher, Nina Kausch‐Busies et al. · Journal of the American Chemical Society · 2014 · 94 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
1–5 of 30